Cargando…

Eltrombopag plus cyclosporine in refractory immune thrombocytopenia: a single-center study

BACKGROUND: With the development of thrombopoietin receptor agonists, the prognosis of immune thrombocytopenia (ITP) in patients in whom there was a poor response to first-line treatment has greatly improved. However, there are still some patients who are refractory to eltrombopag. OBJECTIVES: To ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Yilei, Shen, Yingying, Liu, Qi, Dong, Jingjie, Xiang, Jingjing, Shen, Yiping, Wu, Liqiang, Zhou, Yuhong, Ye, Baodong, Wu, Dijiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339056/ https://www.ncbi.nlm.nih.gov/pubmed/37456916 http://dx.doi.org/10.1016/j.rpth.2023.100279

Ejemplares similares

First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia
por: Shen, Yingying, et al.
Publicado: (2021)

Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2015)

Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia
por: Maraziti, Giorgio, et al.
Publicado: (2021)

Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome
por: Xu, Liping, et al.
Publicado: (2022)

Acute rhabdomyolysis in hepatitis-associated aplastic anemia patient undergoing allogeneic hematopoietic stem-cell transplantation: case report and literature review
por: Li, Yuzhu, et al.
Publicado: (2022)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopag
por: Nambiar, Vivek, et al.
Publicado: (2016)

Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease
por: Wang, Juan, et al.
Publicado: (2021)

Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study
por: Liu, Qi, et al.
Publicado: (2022)

Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review
por: Shen, Yingying, et al.
Publicado: (2021)

Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus
por: Shima, Natsuki, et al.
Publicado: (2018)

Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
por: Weingarten, Sarah J., et al.
Publicado: (2020)

Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
por: Park, Rojin
Publicado: (2015)

Differentiation of Yin, Yang and Stasis Syndromes in Severe Aplastic Anemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Correlation with Iron Metabolism, cAMP/cGMP, 17-OH-CS and Thyroxine
por: Hu, Huijin, et al.
Publicado: (2021)

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag
por: Anwer, Faiz, et al.
Publicado: (2015)

A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
por: Çekdemir, Demet, et al.
Publicado: (2019)

Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study
por: Shen, Yingying, et al.
Publicado: (2023)

Eltrombopag in long‐term management of pediatric thrombocytopenia
por: Shah, Sanjay J., et al.
Publicado: (2018)

Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway
por: Li, Hangchao, et al.
Publicado: (2022)

Severe Systemic Rash in the Treatment of Hairy Cell Leukemia with Cladribine: Case Report and Literature Review
por: Dong, Huijie, et al.
Publicado: (2020)

Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia
por: Profit, Louise
Publicado: (2006)

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
por: Lambert, Michele P
Publicado: (2016)

Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
por: Wan, Ziqi, et al.
Publicado: (2023)

Response of Eltrombopag in immune thrombocytopenia and acquired idiopathic aplastic anemia: A single-center experience
por: Abbasi, Abdul Muqtadir, et al.
Publicado: (2022)

Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
por: Danish, Fazal A., et al.
Publicado: (2010)

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
por: Danish, Fazal-i-Akbar, et al.
Publicado: (2013)

Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag
por: Tarantino, Michael D., et al.
Publicado: (2014)

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
por: Özdemirkıran, Füsun, et al.
Publicado: (2015)

Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
por: Bidika, Erjola, et al.
Publicado: (2020)

Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia
por: Di Paola, Alessandra, et al.
Publicado: (2020)

Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
por: Güven, Zeynep Tuğba, et al.
Publicado: (2022)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem cell transplantation
por: KARATAŞ, Ayşe, et al.
Publicado: (2022)

Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre
por: Shen, Yingying, et al.
Publicado: (2023)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

A composite mouse model of aplastic anemia complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children of China: A single-center observational study
por: Cheng, Xiaoling, et al.
Publicado: (2019)

The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia
por: Zhu, Ningning, et al.
Publicado: (2018)

Refractory immune thrombocytopenia. Successful treatment with repeated cyclosporine A: two case reports
por: Hlusi, Antonin, et al.
Publicado: (2015)

Eltrombopag Use in Thrombocytopenia for Endoscopic Submucosal Dissection of a Gastric Carcinoid
por: Kolb, Jennifer M., et al.
Publicado: (2014)

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0hl763pr8p058g9bk8rg4gosfp